Main > ONCOLOGY (**) > MyeloFibrosis *** > Treatment > USA. C. Fedratinib Cap.
USA. C. Fedratinib Cap.'s subsections
(*) CA Approval Date: 2020. 09.21.
(*) EU Approval Date: 2021. 02.08
(*) USA Approval Date: 2019. 08.16.
Company
Company ACQ. By:
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2019. 11.19
TradeMark
TradeMark Web-Site
USA. C. Fedratinib Cap.'s products
This section has no products